PNPLA3 genotype and fibrosis-4 index predict cardiovascular diseases of Japanese patients with histopathologically-confirmed NAFLD

Código QR

PNPLA3 genotype and fibrosis-4 index predict cardiovascular diseases of Japanese patients with histopathologically-confirmed NAFLD

Abstract Background Reliable noninvasive predictors of the top three causes of death [cardiovascular diseases (CVDs), malignancies, and liver-related events in patients with non-alcoholic fatty liver disease (NAFLD)] have not yet been determined. Methods We retrospectively investigated the incidence...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Norio Akuta, Yusuke Kawamura, Yasuji Arase, Satoshi Saitoh, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Yoshiyuki Suzuki, Fumitaka Suzuki, Kenji Ikeda, Hiromitsu Kumada
Formato:	article
Lenguaje:	EN
Publicado:	BMC 2021
Materias:	Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis Cardiovascular diseases Malignancies Liver-related events FIB-4 index Diseases of the digestive system. Gastroenterology RC799-869
Acceso en línea:	https://doaj.org/article/28b14a49534747ce92df6ef7f9fa3ab2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice
por: Masahiro Matsui, et al.
Publicado: (2021)

Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes
por: Apollinariya V. Bogolyubova, et al.
Publicado: (2017)

Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis
por: Filip R, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?
por: Ekaterina E. Mishina, et al.
Publicado: (2017)

Association of insulin resistance and non-alcoholic fatty liver disease
por: Ekaterina E. Mishina, et al.
Publicado: (2021)

EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTS
por: A. V. Bogolyubova, et al.
Publicado: (2019)

Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta‐analysis
por: Shahinul Alam, et al.
Publicado: (2021)

Role of oxidative stress and glutathione system in the pathogenesis of nonalcoholic fatty liver disease
por: T. E. Promenasheva, et al.
Publicado: (2014)

Cholesterol Metabolism: A Double-Edged Sword in Hepatocellular Carcinoma
por: Fangli Zhou, et al.
Publicado: (2021)

Autophagy: a new target for nonalcoholic fatty liver disease therapy
por: Mao YQ, et al.
Publicado: (2016)

E-Selectin-Dependent Inflammation and Lipolysis in Adipose Tissue Exacerbate Steatosis-to-NASH Progression via S100A8/9Summary
por: Robim M. Rodrigues, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease (NAFLD) – a new factor that interplays between inflammation, malnutrition, and atherosclerosis in elderly hemodialysis patients
por: Mikolasevic I, et al.
Publicado: (2014)

White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in MiceSummary
por: Sadatsugu Sakane, et al.
Publicado: (2021)

Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease
por: Na Fei, et al.
Publicado: (2020)

Identification of key genes and pathways in mild and severe nonalcoholic fatty liver disease by integrative analysis
por: Jin Feng, et al.
Publicado: (2021)

NAFLD Nutritional Management: Results from a Multidisciplinary Approach
por: Sara Raquel Osório Policarpo, et al.
Publicado: (2021)

Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
por: Gwyneth Shook Ting Soon, et al.
Publicado: (2021)

Testosterone deficiency and non-alcoholic fatty liver disease in men with type 2 diabetes mellitus
por: Irina A. Khripun, et al.
Publicado: (2019)

Analysis of prevalence of risk factor of nonalcoholic fatty liver disease in the Buryat Republic
por: E. G. Naydanova
Publicado: (2015)

Anti-NAFLD Effect of Djulis Hull and Its Major Compound, Rutin, in Mice with High-Fat Diet (HFD)-Induced Obesity
por: Yu-Tang Tung, et al.
Publicado: (2021)

A nomogram for predicting metabolic steatohepatitis: The combination of NAMPT, RALGDS, GADD45B, FOSL2, RTP3, and RASD1
por: Liao Shenling, et al.
Publicado: (2021)

Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases
por: Jorge Gutiérrez-Cuevas, et al.
Publicado: (2021)

MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis
por: Huang J, et al.
Publicado: (2021)

Association Between the Triglyceride–Glucose Index and Outcomes of Nonalcoholic Fatty Liver Disease: A Large-Scale Health Management Cohort Study
por: Liu J, et al.
Publicado: (2021)

Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease
por: Xiaojiaoyang Li, et al.
Publicado: (2021)

Relationship between obesity, metabolic syndrome, and nonalcoholic fatty liver disease in the elderly agricultural and fishing population of Taiwan
por: Shen HC, et al.
Publicado: (2014)

Activated Natural Killer Cell Promotes Nonalcoholic Steatohepatitis Through Mediating JAK/STAT PathwaySummary
por: Feixue Wang, et al.
Publicado: (2022)

QSHY Granules Promote White Adipose Tissue Browning and Correct BCAAs Metabolic Disorder in NAFLD Mice
por: Zhang B, et al.
Publicado: (2021)

Editorial: New Insights Into Understanding and Managing NAFLD
por: Óscar Escribano, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: A Review of Links and Risks
por: Cheung A, et al.
Publicado: (2021)

Biochanin A Regulates Cholesterol Metabolism Further Delays the Progression of Nonalcoholic Fatty Liver Disease
por: Fan Y, et al.
Publicado: (2021)

Therapeutic Effects of Garlic on Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients: A Randomized Clinical Trial
por: Soleimani D, et al.
Publicado: (2020)

Aqueous Metabolite Trends for the Progression of Nonalcoholic Fatty Liver Disease in Female Bariatric Surgery Patients by Targeted <sup>1</sup>H-NMR Metabolomics
por: Emma J. Robinson, et al.
Publicado: (2021)

Correlation Between Psoriasis Severity and Nonalcoholic Fatty Liver Disease Degree Measured Using Controlled Attenuation Parameter
por: Gandha N, et al.
Publicado: (2020)

Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: a cross-sectional study
por: Ye Lu, et al.
Publicado: (2021)

<i>Euphausia pacifica</i> (North Pacific Krill): Review of Chemical Features and Potential Benefits of 8-HEPE against Metabolic Syndrome, Dyslipidemia, NAFLD, and Atherosclerosis
por: Nanae Ishida, et al.
Publicado: (2021)

A Comparative Analysis of Serum Lipids in Patients with Chronic Hepatitis C, Nonalcoholic Fatty Liver Disease and Healthy Controls
por: Valkov I., et al.
Publicado: (2017)

Estimation of the Prevalence of Nonalcoholic Fatty Liver Disease in an Adult Population in Northern China Using the Data Mining Approach
por: Yang T, et al.
Publicado: (2021)

Identification of Hepatic Steatosis in Premenopausal and Postmenopausal Women Based on Phenotypes Combining Triglyceride Levels and Anthropometric Indices: A Cross-Sectional Study
por: Liu PJ, et al.
Publicado: (2021)

Electromagnetic Fields Ameliorate Insulin Resistance and Hepatic Steatosis by Modulating Redox Homeostasis and SREBP-1c Expression in db/db Mice
por: Zhai M, et al.
Publicado: (2021)